Nektar Therapeutics NKTR Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's short-term investments?
- Nektar Therapeutics (NKTR) reported short-term investments of $419.03M in Q1 2026.
- How has Nektar Therapeutics's short-term investments changed year-over-year?
- Nektar Therapeutics's short-term investments increased by 133.1% year-over-year, from $179.74M to $419.03M.
- What is the long-term trend for Nektar Therapeutics's short-term investments?
- Over 5 years (2020 to 2025), Nektar Therapeutics's short-term investments has grown at a -23.2% compound annual growth rate (CAGR), from $862.94M to $230.64M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.